rs4702 — FURIN proBDNF Processing Variant
A 3'UTR regulatory variant where the G allele creates a miR-338-3p binding site that suppresses FURIN expression, reducing cleavage of proBDNF to mature BDNF and shifting neurotrophin signaling toward pro-apoptotic pathways
Details
- Gene
- FURIN
- Chromosome
- 15
- Risk allele
- G
- Clinical
- Risk Factor
- Evidence
- Moderate
Population Frequency
Category
Mood & BehaviorSee your personal result for FURIN
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
The Hidden Switch in Your Brain's Nerve Growth Factory
Every neuron in your brain depends on a steady supply of mature
brain-derived neurotrophic factor11 brain-derived neurotrophic factor
BDNF is a protein that acts like
fertilizer for neurons — it promotes their survival, growth, and
connection-forming (synaptogenesis). Low BDNF is consistently found
in depression, anxiety, and neurodegenerative diseases (BDNF) to
survive, form memories, and regulate mood. But BDNF doesn't start out
active — it's made as a larger, inactive precursor called proBDNF, which
must be cleaved by the enzyme FURIN before it becomes the mature,
beneficial form. A variant in the FURIN gene's regulatory region,
rs4702, controls how much of this essential cleavage enzyme is produced —
and the G allele reduces FURIN levels enough to shift the BDNF system
toward its pro-apoptotic, rather than pro-survival, mode.
The Mechanism
The FURIN gene's 3' untranslated region (3'UTR) is a stretch of RNA
that doesn't code for protein but instead controls how much FURIN
protein is made. The rs4702 variant sits within this regulatory sequence.
When the G allele is present, it creates a binding site for a small
RNA molecule called
miR-338-3p22 miR-338-3p
microRNAs are short RNA sequences that bind to messenger
RNA and suppress translation. miR-338-3p is expressed in the brain and
is involved in neuronal differentiation and axon growth.
Hou and colleagues33 Hou and colleagues
Hou Y, Liang W, Zhang J et al. Schizophrenia-associated
rs4702 G allele-specific downregulation of FURIN expression by miR-338-3p
reduces BDNF production. Schizophr Res, 2018
demonstrated this mechanism in 2018 using luciferase reporter assays:
the G allele allows miR-338-3p to dock on FURIN's 3'UTR and suppress
its expression, while the A allele disrupts the binding site and preserves
FURIN levels. This allele-specific FURIN suppression was then shown to
reduce production of mature BDNF in human cells.
The consequences are significant. When FURIN levels are reduced, more
proBDNF accumulates instead of being converted to mature BDNF. These
two forms of BDNF have opposite effects:
mature BDNF binds TrkB receptors44 mature BDNF binds TrkB receptors
TrkB (tropomyosin receptor kinase B)
is the high-affinity receptor for mature BDNF. Activation promotes
neuronal survival, LTP, and memory consolidation and promotes neuronal
survival and synaptic plasticity, while
proBDNF binds p75NTR receptors55 proBDNF binds p75NTR receptors
p75NTR is a low-affinity neurotrophin
receptor that, when activated by proBDNF, triggers apoptosis
(programmed cell death) and long-term depression of synaptic strength
and can trigger apoptosis and synaptic weakening.
A 2021 review66 2021 review
Wang M, Xie Y, Qin D. Proteolytic cleavage of proBDNF
to mBDNF in neuropsychiatric and neurodegenerative diseases.
Brain Res Bull, 2021
concluded that "insufficient proBDNF transformation into mature BDNF
is potentially critical to disease pathogenesis" across depression,
anxiety, schizophrenia, Parkinson's disease, and Alzheimer's disease.
The Evidence
Schizophrenia association. The rs4702 G allele emerged as a
genome-wide significant locus from large schizophrenia GWAS studies.
The Hou et al. 2018 paper was specifically motivated by the 108 confirmed
schizophrenia loci from the Psychiatric Genomics Consortium GWAS and
identified rs4702 as a functional 3'UTR variant among these loci.
A 2019 Nature Genetics study77 2019 Nature Genetics study
Schrode N, Ho SM, Yamamuro K et al.
Synergistic effects of common schizophrenia risk variants. Nat Genet,
2019 using CRISPR-edited
iPSCs demonstrated that the rs4702 G allele affects neuronal morphology
and electrophysiological properties in excitatory neurons, with synergistic
effects when combined with other schizophrenia eQTL variants.
FURIN as a cis-eQTL. An eQTL study88 eQTL study
Turpeinen H, Seppälä I, Lyytikäinen
LP et al. A genome-wide expression quantitative trait loci analysis of
proprotein convertase subtilisin/kexin enzymes identifies a novel regulatory
gene variant for FURIN expression and blood pressure. Hum Genet, 2015
of over 1,400 human blood samples confirmed rs4702 as a significant cis-eQTL
for FURIN expression and found nominal associations with blood pressure
phenotypes (diastolic p=0.012, peripheral vascular resistance p=0.003),
suggesting the variant's regulatory effects extend beyond the brain.
Causal evidence from iPSCs. The
Dobrindt et al. 202199 Dobrindt et al. 2021
Dobrindt K, Hoagland DA, Seah C et al. Common
genetic variation in humans impacts in vitro susceptibility to SARS-CoV-2
infection. Stem Cell Reports, 2021
study used CRISPR-based allelic conversion to establish causality: GG
iPSC-derived neurons expressed ~0.74-fold less FURIN than AA counterparts,
confirming that the genotype drives FURIN expression differences, not just
associations.
PTSD and trauma. A
7-year prospective cohort study1010 7-year prospective cohort study
Tamman AJF, Wendt FR, Pathak GA et al.
Attachment style moderates polygenic risk for incident PTSD in US military
veterans. Biol Psychiatry, 2022
of 1,083 trauma-exposed veterans found that rs4702 showed the strongest
gene×environment interaction with cumulative lifetime trauma burden for
incident PTSD, suggesting the FURIN-BDNF axis is particularly relevant
to stress-related psychiatric outcomes.
Neuroprotection after brain injury. In a clinical study of 106 glioma
patients receiving radiotherapy,
Yang and colleagues1111 Yang and colleagues
Yang S, Fu ZZ, Zhang YQ et al. The G to A
transformation of rs4702 polymorphism in 3'UTR of FURIN reduced the risk
of radiotherapy-induced cognitive impairment in glioma patients.
J Cell Mol Med, 2022
found that rs4702-A carriers maintained higher FURIN and BDNF expression
post-treatment and experienced less cognitive impairment, providing
clinical evidence that the A allele's preservation of FURIN activity
matters under neurotoxic stress.
Practical Actions
For GG carriers, the priority is supporting the pathways that compensate for reduced FURIN-mediated proBDNF cleavage. Aerobic exercise is the most robustly evidence-backed intervention for raising mature BDNF levels directly, bypassing the FURIN bottleneck by stimulating BDNF gene transcription via FNDC5/irisin and PGC-1α pathways. Omega-3 fatty acids (EPA/DHA) support neuronal membrane health and have been shown to raise BDNF expression in depressed and healthy populations. Ensuring adequate zinc and magnesium intake matters because both cofactors support metalloprotease activity, including enzymes in the proBDNF processing cascade.
Stress management deserves particular attention for G allele carriers given the documented PTSD interaction: chronic stress suppresses BDNF expression independently of genotype, compounding the FURIN-related reduction. The rs4702 × trauma interaction data suggest that carriers under high cumulative stress load face disproportionately elevated psychiatric risk.
Interactions
The most clinically meaningful interaction is with rs6265 (BDNF Val66Met) in the BDNF gene itself. Both variants converge on reduced mature BDNF availability through different mechanisms: rs4702 G reduces FURIN expression, limiting proBDNF cleavage upstream; rs6265 T (the Met allele) impairs activity-dependent secretion of BDNF downstream. Individuals carrying both the rs4702 G allele and the rs6265 T allele face compound reduction in mature BDNF signaling — reduced production from proBDNF and reduced regulated release of whatever mature BDNF is produced. This combination is a candidate for a compound action targeting both upstream (FURIN support) and downstream (BDNF secretion) components of the neurotrophin pathway.
Nutrient Interactions
Genotype Interpretations
What each possible genotype means for this variant:
Normal FURIN expression and proBDNF processing
The A allele disrupts the binding site for miR-338-3p in FURIN's 3'UTR, preserving FURIN mRNA stability and translation. CRISPR iPSC experiments by Dobrindt et al. 2021 confirmed that AA neuronal cells express approximately 35% more FURIN than GG cells. This translates to more efficient cleavage of proBDNF into mature BDNF intracellularly, tilting the mature BDNF:proBDNF balance toward the pro-survival (TrkB-activating) form. Clinical evidence from Yang et al. 2022 showed that AA glioma patients maintained higher BDNF levels and better cognitive function after radiotherapy compared to G allele carriers.
One risk allele — modest reduction in FURIN expression
Heterozygous AG carriers show intermediate FURIN expression between the AA and GG extremes. Because additive dosage of the G allele correlates with progressively reduced FURIN expression (confirmed by the eQTL data of Turpeinen et al. 2015 and the iPSC data of Dobrindt et al. 2021), one G copy produces a mild but measurable decrease in FURIN levels. The practical neurological consequence is a subtle shift in the mature BDNF:proBDNF balance. While clinical studies primarily characterize the GG homozygote, the PTSD cohort study by Tamman et al. 2022 found that the rs4702 × trauma interaction follows an additive model, with AG carriers showing intermediate risk under high cumulative stress.
Both alleles are G — substantially reduced FURIN expression and proBDNF processing
CRISPR iPSC experiments demonstrated that GG neurons express approximately 0.74-fold less FURIN than AA counterparts — a ~26% reduction confirmed at the causal level. This reduction in FURIN activity creates an upstream bottleneck in BDNF maturation: more of the BDNF pool remains as proBDNF, which binds p75NTR receptors and can promote apoptosis and long-term synaptic depression rather than the pro-survival TrkB signaling driven by mature BDNF.
The schizophrenia GWAS association of rs4702 was among the 108 genome-wide significant loci identified by the Psychiatric Genomics Consortium. The Schrode et al. 2019 Nature Genetics study showed synergistic effects when the rs4702 G allele co-occurs with other schizophrenia eQTL variants, with measurable changes in neuronal morphology and firing properties in excitatory neurons.
The PTSD risk finding (Tamman et al. 2022) is clinically meaningful: GG carriers under high cumulative trauma burden face compounded risk. The interaction was the single strongest gene×environment result in that 1,083-person prospective cohort. Under low trauma conditions, the genotypic difference in PTSD risk was minimal — but under high stress loads, the FURIN-BDNF axis became a significant vulnerability.
In the cognitive neuroprotection study (Yang et al. 2022), GG glioma patients showed lower FURIN and BDNF expression post-radiotherapy and greater cognitive impairment than A allele carriers, providing direct clinical evidence that the GG genotype represents meaningful neurotrophic vulnerability under brain stress.